Product Information
TEXACORT 2.5% SOLUTION is a brand (anda) product labeled by Mission Pharmacal Company, priced at $6.2211 per ML under NDC 00178045501. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Apr 17, 1992.
The High Outlier badge above means this manufacturer's average price in the Hydrocortisone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/mL
Manufacturer
Mission Pharmacal CompanyNDC
00178045501
Classification
Brand (ANDA)
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
HYDROCORTISONEApproval Type
Generic (ANDA)
FDA Application
ANDA081271FDA Approved
4/17/1992
On Market Since
12/15/2011
Pharmacological Classes
Price Statistics
The NADAC for TEXACORT 2.5% SOLUTION has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.2211 per ML |
|---|---|
| All-time high | $6.4104 (Apr 16, 2025) |
| All-time low | $6.1730 (Apr 17, 2024) |
| 52-week high | $6.3284 |
| 52-week low | $6.1987 |
| Median price | $6.3148 |
| Average price | $6.3007 |
| Largest weekly change | +2.0% (Oct 23, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydrocortisone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mission Pharmacal Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocortisone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TEXACORT 2.5% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for TEXACORT 2.5% SOLUTION, manufactured by Mission Pharmacal Company, is $6.2211 per ML (NDC 00178045501), effective Sep 30, 2026.
How has the price of TEXACORT 2.5% SOLUTION changed over time?
Over the history we have for it, the NADAC for TEXACORT 2.5% SOLUTION has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for TEXACORT 2.5% SOLUTION?
Since Apr 17, 2024, the NADAC for TEXACORT 2.5% SOLUTION has ranged from a low of $6.1730 (Apr 17, 2024) to a high of $6.4104 (Apr 16, 2025), with a median of $6.3148 per ML.
Are there cheaper alternatives to TEXACORT 2.5% SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of TEXACORT 2.5% SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TEXACORT 2.5% SOLUTION?
TEXACORT 2.5% SOLUTION (NDC 00178045501) is labeled by Mission Pharmacal Company, and CMS classifies it as a brand (anda) product.